Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.
Blood Adv
; 8(6): 1415-1419, 2024 Mar 26.
Article
in En
| MEDLINE
| ID: mdl-38134300
Full text:
1
Database:
MEDLINE
Main subject:
Receptors, Fc
/
Anemia, Aplastic
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2024
Type:
Article
Affiliation country:
Japan